Amin Sharifan

Projects (Extract Research Database)

Running projects

AI Methods

Duration: 01/08/2025–31/01/2026
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner

Add to favorites

AI Methods

Duration: 01/08/2025–31/01/2026
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner

Add to favorites

Comparative Effectiveness and Harms of Influenza Vaccines in Nonpregnant Adults Who Are Not Immunocompromised

Duration: 15/07/2025–31/01/2026
Principle investigator for the project (University for Continuing Education Krems): Andreea Dobrescu
Funding: andere internationale Organisationen

Add to favorites

Statistically non-sIGNificAnt resuLts (SIGNAL): a standard framework for reporting results in evidence synthesis

Duration: 01/04/2025–31/03/2028
Principle investigator for the project (University for Continuing Education Krems): Amin Sharifan
Funding: Bundesländer (inkl. deren Stiftungen und Einrichtungen)

Add to favorites

Evidence Review on Pharmacologic Treatment of Chronic Insomnia

Duration: 01/03/2025–28/02/2027
Principle investigator for the project (University for Continuing Education Krems): Andreea Dobrescu
Funding: Sonstige

Add to favorites

Workflow Validation of the (semi-) automated Review Features of the Epistemonikos Sustainable Knowledge Platform: A Prospective Validation Study

Duration: 01/12/2024–30/09/2025
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner

Add to favorites

Assessing the Impact of Unpublished Data on Network Meta-Analysis Outcomes in Outpatient Adults with Acute Migraine- A Case-Study

Duration: 01/11/2024–30/04/2025
Principle investigator for the project (University for Continuing Education Krems): Andreea Dobrescu

Add to favorites

Update of a Rapid Review on Outpatient Treat-ment of Confirmed COVID-19 (Version 3)

Duration: 01/09/2024–30/09/2025
Principle investigator for the project (University for Continuing Education Krems): Isolde Sommer
Funding: Sonstige

Add to favorites

Interpretation of Non-significant Differences

Duration: 01/12/2022–31/12/2024
Principle investigator for the project (University for Continuing Education Krems): Gerald Gartlehner

Add to favorites

Publications (Extract Research Database)

Abdulazeem, H.; Borges do Nascimento, I.J.; Weerasekara, I.; Sharifan, A.; Grandi Bianco, V.; Cunningham, C.; Kularathne, I.; Deeken, G.; de Barros, J.; Sathian, B.; Østengaard, L.; Lamontagne-Godwin, F.; van Hoof, J.; Lazeri, L.; Redlich, C.; Marston, H.R.; Alistair Dos Santos, R.; Azzopardi-Muscat, N.; Yon, Y.; Novillo-Ortiz, D. (2025). Use of Digital Health Technologies for Dementia Care: Bibliometric Analysis and Report. JMIR Ment Health, 12:e64445: 10.2196/64445

Feigin, V. L. ; Vos, T.; Nair, B. S.; Hay, S. I.; Abate, Y. H.; Abd Al Magied, A. H. A.; et al. (2025). Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health, 10: e203-27

GBD 2021 Europe Life Expectancy Collaborators; Steel, N., Sharifan, A. (2025). Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. Lancet Public Health, 10: e172–88

GBD 2021 Global Subarachnoid Hemorrhage Risk Factors Collaborators (2025). Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage. The Global Burden of Disease Study 2021. JAMA Neurology, 10.1001/jamaneurol.2025.1522: E1-E23

GBD 2021 Suicide Collaborators; Davis Weaver, N.; Sharifan, A.; (2025). Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health, 10: e189-e202

Haeuser, E.; Byrne, S.; Nguyen, J.; Raggi, C.; McLaughlin, S.A.; Bisignano, C.; et al. Sharifan, A: (2025). Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, Volume 406, Issue 10500: 235-260

Haeuser, E.; Byrne, S.; Nguyen, J.; Raggi, C.; McLaughlin, S.A.; Bisignano, C.; et al. Sharifan, A: (2025). Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, Volume 406, Issue 10500: 235-260

Kerr, J. A.; Patton, G. C.; Cini, K. I.; Abate, Y. H.; Abbas, N.; Abd Al Magied, A. H. A.; et al. (2025). Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet, 405: 785-812

Li, S.; Zhang, L.; Wang, Y.; Xie, R.; Chen, W.; Soo Lee, M.; Amer, Y.S.; Sharifan, A.; Hussein, H.; Li, H. (2025). Development and validation a methodology model for traditional Chinese medicine good practice recommendation: an exploratory sequential mixed methods study. Frontiers in Pharmacology, 16:1501634: 10.3389/fphar.2025.1501634

M. Ng,; E. Gakidou,; J. Lo,; Y. H. Abate,; C. Abbafati,; N. Abbas,; et al. (2025). Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet, 405: 813-38

Nevill, C.R.; Sharifan, A.; O'Mahony, A.; Tahir, H.; Robinson, W.; Modha, U.; Kahale, L.A.; Khamis, A.M.; Akl, E.A.; Smith, E.A.; Sutton, A.J.; Freeman, S.C.; Cooper, N.J. (2025). Capturing the influx of living systematic reviews: a systematic methodological survey. Journal of Clinical Epidemiology, 186: 111904

Nevill, C.R.; Sharifan, A.; O'Mahony, A.; Tahir, H.; Robinson, W.; Modha, U.; Kahale, L.A.; Khamis, A.M.; Akl, E.A.; Smith, E.A.; Sutton, A.J.; Freeman, S.C.; Cooper, N.J. (2025). Capturing the influx of living systematic reviews: a systematic methodological survey. Journal of Clinical Epidemiology, 186: 111904

Oh, J.; Kim, S.; Kim, M. S.; Abate, Y. H.; Abd ElHafeez, S.; Abdelkader, A.; et al. (2025). Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Respiratory Medicine, 13, 5: 425-446

Rafferty, Q.; Stafford, L.K.; Vos, T.; Thomé, F.S.; Aalruz, H.; Abate, Y.H.; et al. Sharifan, A.; (2025). Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Global Health, Vol. 13 Issue 8: e1378-e1395

Rafferty, Q.; Stafford, L.K.; Vos, T.; Thomé, F.S.; Aalruz, H.; Abate, Y.H.; et al. Sharifan, A.; (2025). Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Global Health, Vol. 13 Issue 8: e1378-e1395

Romantski, O.; Sharifan, A.; Fiander, M.; Ng, E.; Bruschettini, M.; supported by the Cochrane Neonatal Review Group and Cochrane Sweden (2025). Midazolam for sedation of infants in the neonatal intensive care unit (Review). Cochrane Database of Systematic Reviews, Issue 7.: Art. No.: CD002052.

S. Lee, Y. Son, J. Hwang, M. S. Kim, J. I. Shin, N. J. Kassebaum, et al. (2025). Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study. Nature Medicine, https://doi.org/10.1038/s41591-025-03624-8: https://doi.org/10.1038/s41591-025-03624-8

Sharifan, A. (2025). Navigating the grey area: “Trend” statements to report statistical findings in the critical care literature. Journal of Critical Care, 89: 155162

Sharifan, A. (2025). From “No Difference” to “Trending”: misinterpretation of statistical analysis in animal studies. Naunyn-Schmiedeberg's Archives of Pharmacology, https://doi.org/10.1007/s00210-025-04440-0: https://doi.org/10.1007/s00210-025-04440-0

Sharifan, A. (2025). Bridging knowledge gaps in phytotherapy for a neglected zoonotic disease: Rift valley fever. Biomedicine & Pharmacotherapy, 187: https://doi.org/10.1016/j.biopha.2025.118092

Load more
from
Back to top